Obelis European Authorized Representative Center
"CE Marking Consultants with a Reputation for Excellence"AIMDD (Active Implantable Medical Device Directive) 90/385/EEC has been in place since June 20, 1990. This directive applies to devices according to Article 2.C AIMDD, which defines an active implantable medical device as:
“any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure” additionally the directive requires that all active implantable medical device manufacturers must affix CE-Marking to the Directive in order to place their devices on the European Market. The AIMDD 90/385/ EEC also mentions the language requirement issue in Article 4.4, “when a device is put into service, Member States may require the information described in sections 13, 14 and 15 of Annex I to be in their national language(s).”
AIMDD 90/385/EEC | Structure | Scope | Compliance | AIMDD 90/385/EEC Services
Last updated Jun 11, 2012
Contact Us now to find out more.
Our sister company GiDoS s.p.r.l. provides REACH, WEEE,
RoHS and P&PW compliance services.
Visit GiDoS.net
Directive codes: 93/68/EEC - MSD 2006/42/EC - TSD 2009/48/EC - CPR 305/2011/EU - ATEX 94/9/EC - MVD 2007/46/EC - 90/385/EEC - PED 97/23/EC - R&TTE 1999/5/EC - 2004/108/EC - PPE 89/686/EEC - LVD 2006/95/EC - 76/768/EEC - GPSD 2001/95/EC - IVDD 98/79/EC - MDD 93/42/EEC -
General Sitemap | Sitemap EU Directives | European Directives Articles
Contact Us | Terms & Conditions
Copyright © Obelis SA 2008
Registered Office Address
Av. de Tervuren 34
BTE 44, B-1040 Brussels
Belgium
Tel: +(32) 2 732-59-54
Fax: +(32) 2 732-60-03
mail@obelis.net
Registered Address
Bd Général Wahis 53
1030 Brussels
Belgium
Tel: +(32) 2 732-59-54
Fax: +(32) 2 732-60-03
mail@obelis.net
